Dr Mats Reslow, CMC Project manager
Mats Reslow is a research and development professional with more than 25 years of experience in biopharmaceuticals and drug delivery. He has a proven record of developing projects from early research through clinical development and regulatory submission. He worked as Head of Research in Bioglan Therapeutics AB and SkyePharma. Between 2004 and 2016, he was a Principal Scientist at NovoNordisk A/S, coordinating the processing related to drug delivery and life cycle management of proteins, antibodies/fragment and protein conjugates within growth disorders, diabetes, haemophilia and inflammation. Since 2016, he has been an independent consultant advising on drug development, formulation, CMC, IPR, and intelligence.
LinkedIn profile is here »